JP2012507525A5 - - Google Patents

Download PDF

Info

Publication number
JP2012507525A5
JP2012507525A5 JP2011534550A JP2011534550A JP2012507525A5 JP 2012507525 A5 JP2012507525 A5 JP 2012507525A5 JP 2011534550 A JP2011534550 A JP 2011534550A JP 2011534550 A JP2011534550 A JP 2011534550A JP 2012507525 A5 JP2012507525 A5 JP 2012507525A5
Authority
JP
Japan
Prior art keywords
benzo
hydroxy
imidazole
carboxamide
piperidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011534550A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012507525A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/052228 external-priority patent/WO2010051085A1/en
Publication of JP2012507525A publication Critical patent/JP2012507525A/ja
Publication of JP2012507525A5 publication Critical patent/JP2012507525A5/ja
Withdrawn legal-status Critical Current

Links

JP2011534550A 2008-10-30 2009-07-30 7−ヒドロキシ−ベンゾイミダゾール−4−イル−メタノン誘導体およびこれを含むpbk阻害剤 Withdrawn JP2012507525A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10980108P 2008-10-30 2008-10-30
US61/109,801 2008-10-30
PCT/US2009/052228 WO2010051085A1 (en) 2008-10-30 2009-07-30 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same

Publications (2)

Publication Number Publication Date
JP2012507525A JP2012507525A (ja) 2012-03-29
JP2012507525A5 true JP2012507525A5 (enExample) 2012-09-06

Family

ID=42129188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011534550A Withdrawn JP2012507525A (ja) 2008-10-30 2009-07-30 7−ヒドロキシ−ベンゾイミダゾール−4−イル−メタノン誘導体およびこれを含むpbk阻害剤

Country Status (14)

Country Link
US (1) US20110263566A1 (enExample)
EP (1) EP2364087A4 (enExample)
JP (1) JP2012507525A (enExample)
KR (1) KR20110079847A (enExample)
CN (1) CN102271514A (enExample)
AU (1) AU2009310310A1 (enExample)
BR (1) BRPI0919977A2 (enExample)
CA (1) CA2741988A1 (enExample)
CO (1) CO6361855A2 (enExample)
IL (1) IL212544A0 (enExample)
MX (1) MX2011004414A (enExample)
RU (1) RU2011121665A (enExample)
WO (1) WO2010051085A1 (enExample)
ZA (1) ZA201103964B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5339291B2 (ja) 2006-08-10 2013-11-13 オンコセラピー・サイエンス株式会社 乳癌に関連する遺伝子およびポリペプチド
AU2009276548A1 (en) * 2008-07-30 2010-02-04 Oncotherapy Science, Inc. Benzoimidazole derivatives and glycogen synthase kinase-3 beta inhibitors containing the same
JP2012509249A (ja) * 2008-11-20 2012-04-19 オンコセラピー・サイエンス株式会社 7−ヒドロキシ−ベンゾイミダゾール−4−イル−メタノン誘導体を含むグリコーゲン合成酵素キナーゼ−3ベータ阻害剤
CN101619058A (zh) * 2009-01-08 2010-01-06 上海交通大学 一种苯并咪唑-4-酰胺型衍生物
KR102232744B1 (ko) * 2012-12-18 2021-03-26 이도르시아 파마슈티컬스 리미티드 P2x7 수용체 길항제로서의 인돌 카르복사미드 유도체
CN105017221B (zh) * 2014-04-30 2019-05-28 中国医学科学院药物研究所 苯并咪唑衍生物及其制法和药物组合物与用途
BR112018001688B1 (pt) 2015-07-30 2023-05-02 Daiichi Sankyo Company, Limited Uso de um composto
WO2019124608A1 (ko) * 2017-12-22 2019-06-27 경상대학교병원 4'-(p-톨루엔설포닐아미도)-4-하이드록시칼콘을 유효성분으로 함유하는 류마티스 관절염 예방 또는 치료용 약학 조성물
CN109320461B (zh) * 2018-12-12 2020-02-07 迪嘉药业集团有限公司 一种替米沙坦中间体的制备方法
MA55556A (fr) 2019-04-02 2022-02-09 Aligos Therapeutics Inc Composés ciblant prmt5

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288100B1 (en) * 1995-06-06 2001-09-11 American Home Products Corporation Benzimidazole derivatives
US20040002524A1 (en) * 2002-06-24 2004-01-01 Richard Chesworth Benzimidazole compounds and their use as estrogen agonists/antagonists
KR100791252B1 (ko) * 2003-01-23 2008-01-03 크리스탈지노믹스(주) 글리코겐 합성효소 키나아제 3β 활성 억제제, 이의제조방법 및 이를 유효성분으로 함유하는 약학 조성물

Similar Documents

Publication Publication Date Title
JP2012507525A5 (enExample)
US6130235A (en) Compounds and methods to treat cardiac failure and other disorders
JP4357965B2 (ja) メタボトロピックグルタミン酸受容体−5のヘテロアリール置換ピロールモジュレーター
RU2011121665A (ru) Производные 7-гидроксибензимидазол-4-илметанона и содержащие их ингибиторы рвк
JP2010516635A5 (enExample)
JP2011510929A5 (enExample)
JP2010507664A (ja) ベンズイミダゾール化合物
HRP20010484A2 (en) Substituted benzimidazoles and their preparation and use
JP2008513496A5 (enExample)
JP2014516360A5 (enExample)
DK2621916T3 (en) Benzazole derivatives as histamine H 4 receptor ligands
KR20080094962A (ko) 아미드 유도체 또는 그의 염
ZA200207112B (en) New CCR5 modulators: benzimidazoles or benzotriazoles.
ATE473221T1 (de) 1-(1-benzylpiperidin-4-yl)benzimidazol-5- carbonsäurederivate zur behandlung von diabetes mellitus
JP5892550B2 (ja) 縮合イミダゾール誘導体
RU2007130144A (ru) Гетероциклические соединения в качестве антагонистов cccr2b
EA201001645A1 (ru) Хинуклидиновые производные в качестве антагонистов мускаринового м3 рецептора
EP1797076A1 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
CN101031562A (zh) 咪唑-5-羧酸类衍生物、制备方法及其应用
JP2014521620A5 (enExample)
JP2011510026A5 (enExample)
EA200501594A1 (ru) Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора
CN1509271A (zh) 4-(苯基-哌啶-4-基亚基-甲基)-苯甲酰胺衍生物及其在治疗疼痛、焦虑或胃肠疾病中的用途
MX2012001799A (es) Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3).
JP2012509249A5 (enExample)